# Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies

> **NCT00449280** · PHASE1 · COMPLETED · sponsor: **University of Chicago** · enrollment: 34 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** Sorafenib
- **DRUG:** Rapamycin
- **DRUG:** Rapamycin

## Key facts

- **NCT ID:** NCT00449280
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2009-06
- **Final completion:** 2009-09
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449280, "Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00449280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*